Retatrutide research peptide vial, factory sealed, supplied in Egypt

Retatrutide

10 mg
LE 7,700.00 EGP
Skip to product information
Retatrutide research peptide vial, factory sealed, supplied in Egypt

Research Peptide

Retatrutide

LE 7,700.00 EGP
Size
Compound
Retatrutide
Presentation
10 mg
Form
Lyophilised powder, factory-sealed vial
Supply
Authorized reseller · never repackaged
Documentation
Manufacturer COA on request
Storage
Store at −20 °C, protected from light
Availability
In stock · dispatched within 48 hours

Retatrutide is a synthetic 39-amino-acid peptide derived from the glucagon peptide family. It is characterised in the literature as a triple agonist, with binding activity at the GLP-1, GIP, and glucagon receptors.

Published research has examined this multi-receptor profile in the context of glucose regulation, appetite signalling, and energy expenditure. Studies report effects on satiety pathways and metabolic rate in trial populations; gastrointestinal discomfort and fatigue are also documented among reported adverse events, most frequently during early dose escalation.

Supplied as a lyophilised powder in a factory-sealed vial. Store at −20 °C, protected from light. For laboratory research use only.

Related compounds

Research use only

All products supplied by Space Pep are intended strictly for laboratory research purposes. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. They are not approved for human or veterinary consumption and must not be administered to humans or animals. By purchasing, the buyer confirms they are a qualified researcher or institution and accepts full responsibility for lawful handling, storage, and disposal in their jurisdiction.